Recent Advances in Oligo Purity and Sequence Determination by LC–MS: Maximizing Throughput, Confidence, and Coverage
Tuesday, November 15th 2022 Morning Session: 11am EST|8am PST|4pm GMT|5pm CET Afternoon Session: 2pm EST|11am PST|7pm GMT|8pm CET Analyzing oligos? Join us to learn about novel, automated, and integrated software to support the analysis of the CQAs of oligos using LC–HRAM MS. Purity and sequencing data will be presented for a multitude of oligos including antisense, aptamer, and long synthetic samples.
Register Free: https://www.chromatographyonline.com/lcgc/oligo_purity
Event Overview:
Oligonucleotides (oligos) have become fast-growing modalities in recent years. Along with the development of these candidates has come the increased need for robust analytical methods and easy-to-use data analysis workflows to characterize them. Critical quality attributes of oligos include their mass, purity, and sequence – each of which can be difficult, time consuming, and tedious to analyze. As a result, software that supports these efforts can be of great value. In this work, we present novel, automated, and integrated software to support these workflows using LC–HRAM MS instruments. Purity and sequencing data are presented for a multitude of oligos including antisense, aptamer, and long synthetic samples.
Key Learning Objectives:
- Techniques for analyzing the critical quality attributes (CQAs) of oligos—including their mass, purity, and sequence
- How novel, automated, and integrated software can facilitate the analysis of oligo CQAs using LC–HRAM MS instruments.
- Purity and sequencing data for a multitude of oligos including antisense, aptamer, and long synthetic samples
Who Should Attend:
Analytical staff in biopharmaceutical companies working on the analysis and characterization of oligonucleotides
Speaker
Peter Rye, PhD
Application Engineer Pre Sales
Agilent Technologies
Peter Rye is a technical sales specialist with Agilent Technologies, located in Lexington, Massachusetts, just outside of Boston. He has been with Agilent for 11 years developing LC, RapidFire, and mass spec methods on a wide range of molecules. Prior to Agilent, Peter earned his PhD in Biochemistry from the Essigmann Laboratory at Massachusetts Institute of Technology and worked in analytical development groups for BioTove and BIOCIUS, the original companies that developed the RapidFire platform. In his spare time, you can find Peter relaxing with his wife and kids in Beverly, Massachusetts, and staying active outdoors.
Register Free: https://www.chromatographyonline.com/lcgc/oligo_purity
Advances in Non-Targeted Analysis for PFAS in Environmental Matrices
March 27th 2025David Megson from Manchester Metropolitan University in Manchester, UK, spoke to LCGC International about the latest developments in non-targeted analysis (NTA) of per- and polyfluoroalkyl substances (PFAS) in environmental matrices based on a recent systematic review paper he has collaboratively published (1).
Study Explores Thin-Film Extraction of Biogenic Amines via HPLC-MS/MS
March 27th 2025Scientists from Tabriz University and the University of Tabriz explored cellulose acetate-UiO-66-COOH as an affordable coating sorbent for thin film extraction of biogenic amines from cheese and alcohol-free beverages using HPLC-MS/MS.
Multi-Step Preparative LC–MS Workflow for Peptide Purification
March 21st 2025This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid chromatography–mass spectrometry (LC–MS). The process involves optimizing separation conditions, scaling-up, fractionating, and confirming purity and recovery, using a single LC–MS system. High purity and recovery rates for synthetic peptides such as parathormone (PTH) are achieved. The method allows efficient purification and accurate confirmation of peptide synthesis and is suitable for handling complex preparative purification tasks.
